✦ LIBER ✦

Is anti-TNF switching in refractory Still’s disease safe and effective?

✍ Scribed by Nadia Emi Aikawa; Ana Cristina de Medeiros Ribeiro; Carla Gonçalves Schain Saad; Rosa Maria Rodrigues Pereira; Mauricio Levy; Clovis A. Silva; Eloísa Bonfá; Jozélio Freire de Carvalho

Publisher: Springer
Year: 2011
Tongue: English
Weight: 110 KB
Volume: 30
Category: Article
ISSN: 0770-3198
DOI: 10.1007/s10067-011-1735-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rituximab is an effective and safe thera

Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia

✍ Francisco Javier Peñalver; Alberto Alvarez-Larrán; Jose Luis Díez-Martin; Laura 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 229 KB

Cyclosporin A is effective, but not safe

Cyclosporin A is effective, but not safe, in the management of Behçet's disease

✍ B. Wechsler; E. B. Mertani; P. le Hoang; F. de Groc; J. C. Piette; H. Beaufils; 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 1 views

1) recently reported the effectiveness and safety of cyclosporin A (CsA) treatment in patients with Behqet's disease. We have also used CsA in Behqet's disease patients and have noted similar degrees of effectiveness, but we have rather different findings with respect to renal tolerance. Of 150 pat

TNF dose reduction and shortening of dur

TNF dose reduction and shortening of duration of isolated limb perfusion for locally advanced soft tissue sarcoma of the extremities is safe and effective in terms of long-term patient outcome

✍ Miriam L. Hoven-Gondrie; Esther Bastiaannet; Robert J. van Ginkel; Albert J.H. S 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB